MOLN Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Molecular Partners AG

Watchlist Manager

Watchlist

Price: 3.1 CHF -1.59% Market Closed

Market Cap: CHf125.1m

	Molecular Partners AG SIX:MOLN	CH
	CF Industries Holdings Inc NYSE:CF	US
A	Appian Corp SWB:910	US
S	Starpharma Holdings Ltd XMUN:PQ6	AU
	Jupiter Energy Ltd ASX:JPR	AU
	Starpharma Holdings Ltd ASX:SPL	AU
	Addex Therapeutics Ltd F:APE	CH
	CleanGo Innovations Inc F:APO	CA
P	PMB Technology Bhd KLSE:PMBTECH	MY
	Standard Chartered PLC LSE:STAN	UK
J	Jakarta Setiabudi Internasional Tbk PT IDX:JSPT	ID

Profitability Summary

Molecular Partners AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Sustainable 3Y Average Gross Margin

33%

Low Operating Margin

Negative 3Y Average Operating Margin

-2 217%

Low Net Margin

Negative 3Y Average Net Margin

-2 284%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-2 080%

Negative ROE

-62%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-802%

ROIC is Increasing

-892% > -748%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.